A Synopsis of Clinical Pharmacokinetic Alterations in Advanced CKD
about
Guidance to develop individual dose recommendations for patients on chronic hemodialysis.Pharmacotherapeutic considerations for chronic pain in chronic kidney and end-stage renal diseaseIndoxyl Sulfate Upregulates Liver P-Glycoprotein Expression and Activity through Aryl Hydrocarbon Receptor Signaling.
P2860
A Synopsis of Clinical Pharmacokinetic Alterations in Advanced CKD
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A Synopsis of Clinical Pharmacokinetic Alterations in Advanced CKD
@ast
A Synopsis of Clinical Pharmacokinetic Alterations in Advanced CKD
@en
A Synopsis of Clinical Pharmacokinetic Alterations in Advanced CKD
@nl
type
label
A Synopsis of Clinical Pharmacokinetic Alterations in Advanced CKD
@ast
A Synopsis of Clinical Pharmacokinetic Alterations in Advanced CKD
@en
A Synopsis of Clinical Pharmacokinetic Alterations in Advanced CKD
@nl
prefLabel
A Synopsis of Clinical Pharmacokinetic Alterations in Advanced CKD
@ast
A Synopsis of Clinical Pharmacokinetic Alterations in Advanced CKD
@en
A Synopsis of Clinical Pharmacokinetic Alterations in Advanced CKD
@nl
P2860
P356
P1433
P1476
A Synopsis of Clinical Pharmacokinetic Alterations in Advanced CKD
@en
P2093
Thomas D. Nolin
P2860
P356
10.1111/SDI.12374
P407
P577
2015-01-01T00:00:00Z